<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02041832</url>
  </required_header>
  <id_info>
    <org_study_id>ILR-Afib-study</org_study_id>
    <secondary_id>S-20130062</secondary_id>
    <nct_id>NCT02041832</nct_id>
  </id_info>
  <brief_title>Detection of Subclinical Atrial Fibrillation in High Risk Patients Using Implantable Loop Recorder</brief_title>
  <official_title>Detection of Subclinical Atrial Fibrillation in High Risk Patients (&gt; 65 Years, Hypertension, Diabetes Mellitus) Using Implantable Loop Recorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Axel Brandes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using implantable loop recorder the investigators wish to detect atrial fibrillation in high
      risk patients and compare it to the results using conventional Holter monitoring. The
      hypothesis is that 10-15% of high risk patients have subclinical atrial fibrillation. The
      investigators want to detect those people so they can receive appropriate anticoagulation
      treatment. The patients will get a comprehensive workup including ecg, echocardiography and
      blood tests.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>First episode of atrial fibrillation</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation between echocardiographic parameters and incidence of atrial fibrillation</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Correlation between biomarkers and incidence of atrial fibrillation</measure>
    <time_frame>1 year</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Arterial Hypertension</condition>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Holter monitoring</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Screening of patients with older age, arterial hypertension and diabetes for paroxysmal atrial fibrillation by using conventional Holter monitoring</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Implantable loop recorder</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Screening of patients with older age, arterial hypertension and diabetes mellitus for paroxysmal atrial fibrillation by using an implantable loop recorder</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional Holter monitoring</intervention_name>
    <description>Patients undergo 72h Holter monitoring</description>
    <arm_group_label>Holter monitoring</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantable loop recorder</intervention_name>
    <description>Implantation of loop recorder with follow-up by remote monitoring</description>
    <arm_group_label>Implantable loop recorder</arm_group_label>
    <other_name>REVEAL XT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 65 years

          -  arterial hypertension (at least dual treatment)

          -  diabetes mellitus (oral antidiabetics or insulin)

        Exclusion Criteria:

          -  known atrial fibrillation

          -  ischaemic heart disease

          -  Current anticoagulation treatment

          -  Ejection fraction &lt;45 %

          -  significant valvular heart disease

          -  previous stroke/transient ischemic attack

          -  peripheral arterial disease

          -  end stage renal disease

          -  thyreotoxicosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Axel Brandes, Assoc. Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Odense University Hospital/University of Southern Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Haderslev Hospital</name>
      <address>
        <city>Haderslev</city>
        <zip>6100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2013</study_first_submitted>
  <study_first_submitted_qc>January 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2014</study_first_posted>
  <last_update_submitted>September 27, 2016</last_update_submitted>
  <last_update_submitted_qc>September 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Axel Brandes</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

